Encompass Health Corporation (EHC) Stock Competitors & Peer Comparison
See (EHC) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EHC | $105.85 | +0.47% | 10.5B | 18.13 | $5.84 | +0.69% |
| HCA | $378.54 | -1.52% | 84B | 13.05 | $29.02 | +0.77% |
| THC | $175.32 | +1.22% | 15.1B | 9.12 | $19.23 | N/A |
| SOLV | $74.95 | -1.30% | 13B | 9.17 | $8.17 | N/A |
| DVA | $194.36 | -1.39% | 12.5B | 18.71 | $10.39 | N/A |
| FMS | $21.57 | -0.28% | 11.6B | 11.35 | $1.90 | +4.02% |
| ENSG | $167.65 | -1.92% | 9.8B | 27.29 | $6.14 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| UHS | $146.11 | -2.67% | 9.1B | 6.10 | $23.95 | +0.54% |
| CHE | $426.41 | -3.06% | 5.7B | 23.26 | $18.32 | +0.55% |
Stock Comparison
EHC vs HCA Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, HCA has a market cap of 84B. Regarding current trading prices, EHC is priced at $105.85, while HCA trades at $378.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas HCA's P/E ratio is 13.05. In terms of profitability, EHC's ROE is +0.25%, compared to HCA's ROE of -1.23%. Regarding short-term risk, EHC is less volatile compared to HCA. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check HCA's competition here
EHC vs THC Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, THC has a market cap of 15.1B. Regarding current trading prices, EHC is priced at $105.85, while THC trades at $175.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas THC's P/E ratio is 9.12. In terms of profitability, EHC's ROE is +0.25%, compared to THC's ROE of +0.41%. Regarding short-term risk, EHC is less volatile compared to THC. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check THC's competition here
EHC vs SOLV Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, SOLV has a market cap of 13B. Regarding current trading prices, EHC is priced at $105.85, while SOLV trades at $74.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas SOLV's P/E ratio is 9.17. In terms of profitability, EHC's ROE is +0.25%, compared to SOLV's ROE of +0.31%. Regarding short-term risk, EHC is less volatile compared to SOLV. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check SOLV's competition here
EHC vs DVA Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, DVA has a market cap of 12.5B. Regarding current trading prices, EHC is priced at $105.85, while DVA trades at $194.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas DVA's P/E ratio is 18.71. In terms of profitability, EHC's ROE is +0.25%, compared to DVA's ROE of -1.33%. Regarding short-term risk, EHC is more volatile compared to DVA. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check DVA's competition here
EHC vs FMS Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, FMS has a market cap of 11.6B. Regarding current trading prices, EHC is priced at $105.85, while FMS trades at $21.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas FMS's P/E ratio is 11.35. In terms of profitability, EHC's ROE is +0.25%, compared to FMS's ROE of +0.07%. Regarding short-term risk, EHC is more volatile compared to FMS. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check FMS's competition here
EHC vs ENSG Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, ENSG has a market cap of 9.8B. Regarding current trading prices, EHC is priced at $105.85, while ENSG trades at $167.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas ENSG's P/E ratio is 27.29. In terms of profitability, EHC's ROE is +0.25%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, EHC is less volatile compared to ENSG. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check ENSG's competition here
EHC vs OSH Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, EHC is priced at $105.85, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas OSH's P/E ratio is -17.65. In terms of profitability, EHC's ROE is +0.25%, compared to OSH's ROE of +4.64%. Regarding short-term risk, EHC is more volatile compared to OSH. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check OSH's competition here
EHC vs UHS Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, UHS has a market cap of 9.1B. Regarding current trading prices, EHC is priced at $105.85, while UHS trades at $146.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas UHS's P/E ratio is 6.10. In terms of profitability, EHC's ROE is +0.25%, compared to UHS's ROE of +0.21%. Regarding short-term risk, EHC is less volatile compared to UHS. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check UHS's competition here
EHC vs CHE Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, CHE has a market cap of 5.7B. Regarding current trading prices, EHC is priced at $105.85, while CHE trades at $426.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas CHE's P/E ratio is 23.26. In terms of profitability, EHC's ROE is +0.25%, compared to CHE's ROE of +0.25%. Regarding short-term risk, EHC is less volatile compared to CHE. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check CHE's competition here
EHC vs LHCG Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, EHC is priced at $105.85, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas LHCG's P/E ratio is 82.83. In terms of profitability, EHC's ROE is +0.25%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, EHC is more volatile compared to LHCG. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check LHCG's competition here
EHC vs MMED Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, MMED has a market cap of 3.4B. Regarding current trading prices, EHC is priced at $105.85, while MMED trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas MMED's P/E ratio is -9.48. In terms of profitability, EHC's ROE is +0.25%, compared to MMED's ROE of -0.09%. Regarding short-term risk, EHC is less volatile compared to MMED. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check MMED's competition here
EHC vs AMED Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, EHC is priced at $105.85, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas AMED's P/E ratio is 39.30. In terms of profitability, EHC's ROE is +0.25%, compared to AMED's ROE of +0.09%. Regarding short-term risk, EHC is more volatile compared to AMED. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check AMED's competition here
EHC vs OPCH Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, OPCH has a market cap of 3.3B. Regarding current trading prices, EHC is priced at $105.85, while OPCH trades at $20.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas OPCH's P/E ratio is 16.30. In terms of profitability, EHC's ROE is +0.25%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, EHC is less volatile compared to OPCH. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check OPCH's competition here
EHC vs BKD Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, BKD has a market cap of 3.1B. Regarding current trading prices, EHC is priced at $105.85, while BKD trades at $12.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas BKD's P/E ratio is -14.80. In terms of profitability, EHC's ROE is +0.25%, compared to BKD's ROE of +401.19%. Regarding short-term risk, EHC is less volatile compared to BKD. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check BKD's competition here
EHC vs LFST Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, LFST has a market cap of 3B. Regarding current trading prices, EHC is priced at $105.85, while LFST trades at $7.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas LFST's P/E ratio is 128.50. In terms of profitability, EHC's ROE is +0.25%, compared to LFST's ROE of +0.02%. Regarding short-term risk, EHC is less volatile compared to LFST. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check LFST's competition here
EHC vs NHC Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, NHC has a market cap of 2.9B. Regarding current trading prices, EHC is priced at $105.85, while NHC trades at $184.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas NHC's P/E ratio is 23.42. In terms of profitability, EHC's ROE is +0.25%, compared to NHC's ROE of +0.12%. Regarding short-term risk, EHC is less volatile compared to NHC. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check NHC's competition here
EHC vs ACHC Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, ACHC has a market cap of 2.1B. Regarding current trading prices, EHC is priced at $105.85, while ACHC trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas ACHC's P/E ratio is -1.93. In terms of profitability, EHC's ROE is +0.25%, compared to ACHC's ROE of -0.44%. Regarding short-term risk, EHC is less volatile compared to ACHC. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check ACHC's competition here
EHC vs SEM Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, EHC is priced at $105.85, while SEM trades at $16.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas SEM's P/E ratio is 15.43. In terms of profitability, EHC's ROE is +0.25%, compared to SEM's ROE of +0.08%. Regarding short-term risk, EHC is more volatile compared to SEM. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check SEM's competition here
EHC vs ASTH Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, EHC is priced at $105.85, while ASTH trades at $37.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas ASTH's P/E ratio is 61.67. In terms of profitability, EHC's ROE is +0.25%, compared to ASTH's ROE of +0.04%. Regarding short-term risk, EHC is less volatile compared to ASTH. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check ASTH's competition here
EHC vs AMEH Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, EHC is priced at $105.85, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas AMEH's P/E ratio is 39.25. In terms of profitability, EHC's ROE is +0.25%, compared to AMEH's ROE of +0.04%. Regarding short-term risk, EHC is less volatile compared to AMEH. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check AMEH's competition here
EHC vs MD Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, MD has a market cap of 1.8B. Regarding current trading prices, EHC is priced at $105.85, while MD trades at $21.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas MD's P/E ratio is 10.46. In terms of profitability, EHC's ROE is +0.25%, compared to MD's ROE of +0.20%. Regarding short-term risk, EHC is less volatile compared to MD. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check MD's competition here
EHC vs SGRY Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, SGRY has a market cap of 1.7B. Regarding current trading prices, EHC is priced at $105.85, while SGRY trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas SGRY's P/E ratio is -22.64. In terms of profitability, EHC's ROE is +0.25%, compared to SGRY's ROE of -0.04%. Regarding short-term risk, EHC is less volatile compared to SGRY. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check SGRY's competition here
EHC vs ADUS Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, ADUS has a market cap of 1.7B. Regarding current trading prices, EHC is priced at $105.85, while ADUS trades at $91.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas ADUS's P/E ratio is 16.92. In terms of profitability, EHC's ROE is +0.25%, compared to ADUS's ROE of +0.09%. Regarding short-term risk, EHC is less volatile compared to ADUS. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check ADUS's competition here
EHC vs AVAH Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, AVAH has a market cap of 1.6B. Regarding current trading prices, EHC is priced at $105.85, while AVAH trades at $7.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas AVAH's P/E ratio is 5.93. In terms of profitability, EHC's ROE is +0.25%, compared to AVAH's ROE of +2.41%. Regarding short-term risk, EHC is less volatile compared to AVAH. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check AVAH's competition here
EHC vs AGL Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, AGL has a market cap of 1.5B. Regarding current trading prices, EHC is priced at $105.85, while AGL trades at $92.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas AGL's P/E ratio is -4.07. In terms of profitability, EHC's ROE is +0.25%, compared to AGL's ROE of -1.46%. Regarding short-term risk, EHC is less volatile compared to AGL. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check AGL's competition here
EHC vs HCSG Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, HCSG has a market cap of 1.4B. Regarding current trading prices, EHC is priced at $105.85, while HCSG trades at $20.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas HCSG's P/E ratio is 21.68. In terms of profitability, EHC's ROE is +0.25%, compared to HCSG's ROE of +0.14%. Regarding short-term risk, EHC is less volatile compared to HCSG. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check HCSG's competition here
EHC vs ARDT Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, ARDT has a market cap of 1.3B. Regarding current trading prices, EHC is priced at $105.85, while ARDT trades at $9.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas ARDT's P/E ratio is 9.82. In terms of profitability, EHC's ROE is +0.25%, compared to ARDT's ROE of +0.09%. Regarding short-term risk, EHC is less volatile compared to ARDT. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check ARDT's competition here
EHC vs CMPS Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, CMPS has a market cap of 1.3B. Regarding current trading prices, EHC is priced at $105.85, while CMPS trades at $13.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas CMPS's P/E ratio is -4.16. In terms of profitability, EHC's ROE is +0.25%, compared to CMPS's ROE of -1.51%. Regarding short-term risk, EHC is less volatile compared to CMPS. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check CMPS's competition here
EHC vs BKDT Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, EHC is priced at $105.85, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas BKDT's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to BKDT's ROE of +401.19%. Regarding short-term risk, EHC is more volatile compared to BKDT. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check BKDT's competition here
EHC vs PNTG Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, PNTG has a market cap of 1.2B. Regarding current trading prices, EHC is priced at $105.85, while PNTG trades at $34.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas PNTG's P/E ratio is 39.83. In terms of profitability, EHC's ROE is +0.25%, compared to PNTG's ROE of +0.09%. Regarding short-term risk, EHC is less volatile compared to PNTG. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check PNTG's competition here
EHC vs AMN Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, AMN has a market cap of 1.1B. Regarding current trading prices, EHC is priced at $105.85, while AMN trades at $28.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas AMN's P/E ratio is -33.71. In terms of profitability, EHC's ROE is +0.25%, compared to AMN's ROE of -0.05%. Regarding short-term risk, EHC is less volatile compared to AMN. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check AMN's competition here
EHC vs INNV Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, INNV has a market cap of 1B. Regarding current trading prices, EHC is priced at $105.85, while INNV trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas INNV's P/E ratio is -94.87. In terms of profitability, EHC's ROE is +0.25%, compared to INNV's ROE of -0.09%. Regarding short-term risk, EHC is less volatile compared to INNV. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check INNV's competition here
EHC vs USPH Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, USPH has a market cap of 978.3M. Regarding current trading prices, EHC is priced at $105.85, while USPH trades at $64.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas USPH's P/E ratio is 128.56. In terms of profitability, EHC's ROE is +0.25%, compared to USPH's ROE of +0.00%. Regarding short-term risk, EHC is less volatile compared to USPH. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check USPH's competition here
EHC vs TALK Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, TALK has a market cap of 871.1M. Regarding current trading prices, EHC is priced at $105.85, while TALK trades at $5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas TALK's P/E ratio is 130.00. In terms of profitability, EHC's ROE is +0.25%, compared to TALK's ROE of +0.01%. Regarding short-term risk, EHC is more volatile compared to TALK. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check TALK's competition here
EHC vs FSHCX Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, FSHCX has a market cap of 829.8M. Regarding current trading prices, EHC is priced at $105.85, while FSHCX trades at $105.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas FSHCX's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to FSHCX's ROE of N/A. Regarding short-term risk, EHC is more volatile compared to FSHCX. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check FSHCX's competition here
EHC vs SNDA Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, SNDA has a market cap of 707.4M. Regarding current trading prices, EHC is priced at $105.85, while SNDA trades at $35.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas SNDA's P/E ratio is -6.06. In terms of profitability, EHC's ROE is +0.25%, compared to SNDA's ROE of -0.35%. Regarding short-term risk, EHC is less volatile compared to SNDA. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check SNDA's competition here
EHC vs EHAB Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, EHC is priced at $105.85, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas EHAB's P/E ratio is -197.14. In terms of profitability, EHC's ROE is +0.25%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, EHC is more volatile compared to EHAB. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check EHAB's competition here
EHC vs GMRS Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, GMRS has a market cap of 570.3M. Regarding current trading prices, EHC is priced at $105.85, while GMRS trades at $12.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas GMRS's P/E ratio is 78.19. In terms of profitability, EHC's ROE is +0.25%, compared to GMRS's ROE of N/A. Regarding short-term risk, EHC is less volatile compared to GMRS. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check GMRS's competition here
EHC vs TOI Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, TOI has a market cap of 468.9M. Regarding current trading prices, EHC is priced at $105.85, while TOI trades at $4.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas TOI's P/E ratio is -13.40. In terms of profitability, EHC's ROE is +0.25%, compared to TOI's ROE of +3.27%. Regarding short-term risk, EHC is less volatile compared to TOI. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check TOI's competition here
EHC vs MCTA Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, EHC is priced at $105.85, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas MCTA's P/E ratio is 419.36. In terms of profitability, EHC's ROE is +0.25%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, EHC is more volatile compared to MCTA. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check MCTA's competition here
EHC vs CCRN Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, CCRN has a market cap of 422.9M. Regarding current trading prices, EHC is priced at $105.85, while CCRN trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas CCRN's P/E ratio is -4.29. In terms of profitability, EHC's ROE is +0.25%, compared to CCRN's ROE of -0.27%. Regarding short-term risk, EHC is more volatile compared to CCRN. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check CCRN's competition here
EHC vs CYH Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, CYH has a market cap of 383.3M. Regarding current trading prices, EHC is priced at $105.85, while CYH trades at $2.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas CYH's P/E ratio is 0.79. In terms of profitability, EHC's ROE is +0.25%, compared to CYH's ROE of +0.06%. Regarding short-term risk, EHC is less volatile compared to CYH. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check CYH's competition here
EHC vs AIRS Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, AIRS has a market cap of 379.5M. Regarding current trading prices, EHC is priced at $105.85, while AIRS trades at $5.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas AIRS's P/E ratio is -31.65. In terms of profitability, EHC's ROE is +0.25%, compared to AIRS's ROE of -0.12%. Regarding short-term risk, EHC is less volatile compared to AIRS. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check AIRS's competition here
EHC vs AUNA Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, AUNA has a market cap of 306.5M. Regarding current trading prices, EHC is priced at $105.85, while AUNA trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas AUNA's P/E ratio is 15.33. In terms of profitability, EHC's ROE is +0.25%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, EHC is less volatile compared to AUNA. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check AUNA's competition here
EHC vs AONC Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, AONC has a market cap of 292.5M. Regarding current trading prices, EHC is priced at $105.85, while AONC trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas AONC's P/E ratio is -11.24. In terms of profitability, EHC's ROE is +0.25%, compared to AONC's ROE of +0.06%. Regarding short-term risk, EHC is more volatile compared to AONC. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check AONC's competition here
EHC vs CSU Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, EHC is priced at $105.85, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas CSU's P/E ratio is 0.67. In terms of profitability, EHC's ROE is +0.25%, compared to CSU's ROE of -0.51%. Regarding short-term risk, EHC is less volatile compared to CSU. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check CSU's competition here
EHC vs JYNT Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, JYNT has a market cap of 126.9M. Regarding current trading prices, EHC is priced at $105.85, while JYNT trades at $8.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas JYNT's P/E ratio is 98.89. In terms of profitability, EHC's ROE is +0.25%, compared to JYNT's ROE of +0.17%. Regarding short-term risk, EHC is less volatile compared to JYNT. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check JYNT's competition here
EHC vs NAKAW Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, NAKAW has a market cap of 116.4M. Regarding current trading prices, EHC is priced at $105.85, while NAKAW trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas NAKAW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to NAKAW's ROE of -0.85%. Regarding short-term risk, EHC is less volatile compared to NAKAW. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check NAKAW's competition here
EHC vs FVE Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, EHC is priced at $105.85, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas FVE's P/E ratio is -5.64. In terms of profitability, EHC's ROE is +0.25%, compared to FVE's ROE of -0.15%. Regarding short-term risk, EHC is less volatile compared to FVE. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check FVE's competition here
EHC vs KDLYW Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, EHC is priced at $105.85, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas KDLYW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to KDLYW's ROE of -0.85%. Regarding short-term risk, EHC is less volatile compared to KDLYW. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check KDLYW's competition here
EHC vs BTMD Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, BTMD has a market cap of 88.2M. Regarding current trading prices, EHC is priced at $105.85, while BTMD trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas BTMD's P/E ratio is 4.65. In terms of profitability, EHC's ROE is +0.25%, compared to BTMD's ROE of -0.23%. Regarding short-term risk, EHC is less volatile compared to BTMD. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check BTMD's competition here
EHC vs DCGO Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, DCGO has a market cap of 65M. Regarding current trading prices, EHC is priced at $105.85, while DCGO trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas DCGO's P/E ratio is -0.35. In terms of profitability, EHC's ROE is +0.25%, compared to DCGO's ROE of -0.89%. Regarding short-term risk, EHC is less volatile compared to DCGO. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check DCGO's competition here
EHC vs ALR Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, EHC is priced at $105.85, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas ALR's P/E ratio is -1.11. In terms of profitability, EHC's ROE is +0.25%, compared to ALR's ROE of -0.15%. Regarding short-term risk, EHC is more volatile compared to ALR. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check ALR's competition here
EHC vs PIII Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, PIII has a market cap of 40.1M. Regarding current trading prices, EHC is priced at $105.85, while PIII trades at $12.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas PIII's P/E ratio is -0.32. In terms of profitability, EHC's ROE is +0.25%, compared to PIII's ROE of +1.85%. Regarding short-term risk, EHC is less volatile compared to PIII. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check PIII's competition here
EHC vs IMAC Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, EHC is priced at $105.85, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas IMAC's P/E ratio is -2.27. In terms of profitability, EHC's ROE is +0.25%, compared to IMAC's ROE of +1183.61%. Regarding short-term risk, EHC is less volatile compared to IMAC. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check IMAC's competition here
EHC vs CCEL Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, CCEL has a market cap of 28.2M. Regarding current trading prices, EHC is priced at $105.85, while CCEL trades at $3.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas CCEL's P/E ratio is -10.94. In terms of profitability, EHC's ROE is +0.25%, compared to CCEL's ROE of +0.16%. Regarding short-term risk, EHC is less volatile compared to CCEL. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check CCEL's competition here
EHC vs CANO-WT Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, EHC is priced at $105.85, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, EHC is less volatile compared to CANO-WT. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check CANO-WT's competition here
EHC vs AIH Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, EHC is priced at $105.85, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas AIH's P/E ratio is -2.78. In terms of profitability, EHC's ROE is +0.25%, compared to AIH's ROE of +1.16%. Regarding short-term risk, EHC is less volatile compared to AIH. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check AIH's competition here
EHC vs CANO Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, EHC is priced at $105.85, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas CANO's P/E ratio is -0.01. In terms of profitability, EHC's ROE is +0.25%, compared to CANO's ROE of -1.49%. Regarding short-term risk, EHC is less volatile compared to CANO. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check CANO's competition here
EHC vs FTRP Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, EHC is priced at $105.85, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas FTRP's P/E ratio is -1.22. In terms of profitability, EHC's ROE is +0.25%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, EHC is less volatile compared to FTRP. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check FTRP's competition here
EHC vs AMS Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, AMS has a market cap of 9.5M. Regarding current trading prices, EHC is priced at $105.85, while AMS trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas AMS's P/E ratio is -6.55. In terms of profitability, EHC's ROE is +0.25%, compared to AMS's ROE of -0.06%. Regarding short-term risk, EHC is less volatile compared to AMS. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check AMS's competition here
EHC vs SYRA Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, SYRA has a market cap of 6.2M. Regarding current trading prices, EHC is priced at $105.85, while SYRA trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas SYRA's P/E ratio is -27.50. In terms of profitability, EHC's ROE is +0.25%, compared to SYRA's ROE of -0.08%. Regarding short-term risk, EHC is less volatile compared to SYRA. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check SYRA's competition here
EHC vs MODV Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, EHC is priced at $105.85, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas MODV's P/E ratio is -0.03. In terms of profitability, EHC's ROE is +0.25%, compared to MODV's ROE of +1.84%. Regarding short-term risk, EHC is more volatile compared to MODV. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check MODV's competition here
EHC vs GBNH Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, EHC is priced at $105.85, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas GBNH's P/E ratio is -0.06. In terms of profitability, EHC's ROE is +0.25%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, EHC is less volatile compared to GBNH. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check GBNH's competition here
EHC vs RHE-PA Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, EHC is priced at $105.85, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, EHC's ROE is +0.25%, compared to RHE-PA's ROE of +2.11%. Regarding short-term risk, EHC is less volatile compared to RHE-PA. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check RHE-PA's competition here
EHC vs RHE Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, EHC is priced at $105.85, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas RHE's P/E ratio is -1.79. In terms of profitability, EHC's ROE is +0.25%, compared to RHE's ROE of -0.36%. Regarding short-term risk, EHC is less volatile compared to RHE. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check RHE's competition here
EHC vs TOIIW Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, TOIIW has a market cap of 4.9M. Regarding current trading prices, EHC is priced at $105.85, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas TOIIW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to TOIIW's ROE of +3.27%. Regarding short-term risk, EHC is less volatile compared to TOIIW. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check TOIIW's competition here
EHC vs ATIP Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, ATIP has a market cap of 3M. Regarding current trading prices, EHC is priced at $105.85, while ATIP trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas ATIP's P/E ratio is -0.03. In terms of profitability, EHC's ROE is +0.25%, compared to ATIP's ROE of +2.05%. Regarding short-term risk, EHC is less volatile compared to ATIP. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check ATIP's competition here
EHC vs IMACW Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, EHC is priced at $105.85, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas IMACW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to IMACW's ROE of +1.05%. Regarding short-term risk, EHC is less volatile compared to IMACW. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check IMACW's competition here
EHC vs TALKW Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, TALKW has a market cap of 753.8K. Regarding current trading prices, EHC is priced at $105.85, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas TALKW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to TALKW's ROE of +0.01%. Regarding short-term risk, EHC is less volatile compared to TALKW. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check TALKW's competition here
EHC vs CCM Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, CCM has a market cap of 703.3K. Regarding current trading prices, EHC is priced at $105.85, while CCM trades at $4.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas CCM's P/E ratio is -1.54. In terms of profitability, EHC's ROE is +0.25%, compared to CCM's ROE of +0.07%. Regarding short-term risk, EHC is less volatile compared to CCM. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check CCM's competition here
EHC vs MNDR Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, MNDR has a market cap of 690.4K. Regarding current trading prices, EHC is priced at $105.85, while MNDR trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas MNDR's P/E ratio is -0.32. In terms of profitability, EHC's ROE is +0.25%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, EHC is less volatile compared to MNDR. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check MNDR's competition here
EHC vs NIVF Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, NIVF has a market cap of 517.3K. Regarding current trading prices, EHC is priced at $105.85, while NIVF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas NIVF's P/E ratio is 0.02. In terms of profitability, EHC's ROE is +0.25%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, EHC is less volatile compared to NIVF. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check NIVF's competition here
EHC vs NVOS Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, NVOS has a market cap of 394.6K. Regarding current trading prices, EHC is priced at $105.85, while NVOS trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas NVOS's P/E ratio is -0.02. In terms of profitability, EHC's ROE is +0.25%, compared to NVOS's ROE of -0.81%. Regarding short-term risk, EHC is less volatile compared to NVOS. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check NVOS's competition here
EHC vs BACK Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, BACK has a market cap of 170.3K. Regarding current trading prices, EHC is priced at $105.85, while BACK trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas BACK's P/E ratio is -0.02. In terms of profitability, EHC's ROE is +0.25%, compared to BACK's ROE of +1.05%. Regarding short-term risk, EHC is less volatile compared to BACK. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check BACK's competition here
EHC vs NIVFW Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, NIVFW has a market cap of 58.9K. Regarding current trading prices, EHC is priced at $105.85, while NIVFW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas NIVFW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, EHC is more volatile compared to NIVFW. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check NIVFW's competition here
EHC vs PIIIW Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, PIIIW has a market cap of 48.8K. Regarding current trading prices, EHC is priced at $105.85, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas PIIIW's P/E ratio is -0.01. In terms of profitability, EHC's ROE is +0.25%, compared to PIIIW's ROE of +1.85%. Regarding short-term risk, EHC is less volatile compared to PIIIW. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check PIIIW's competition here
EHC vs IONM Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, IONM has a market cap of 1.6K. Regarding current trading prices, EHC is priced at $105.85, while IONM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas IONM's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to IONM's ROE of +5.28%. Regarding short-term risk, EHC is less volatile compared to IONM. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check IONM's competition here
EHC vs TLMDW Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, EHC is priced at $105.85, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas TLMDW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, EHC is less volatile compared to TLMDW. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check TLMDW's competition here
EHC vs ATIP-WT Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, EHC is priced at $105.85, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, EHC is less volatile compared to ATIP-WT. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check ATIP-WT's competition here
EHC vs TLMD Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, EHC is priced at $105.85, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas TLMD's P/E ratio is -1.60. In terms of profitability, EHC's ROE is +0.25%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, EHC is more volatile compared to TLMD. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check TLMD's competition here
EHC vs SLHGP Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, EHC is priced at $105.85, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, EHC's ROE is +0.25%, compared to SLHGP's ROE of -0.71%. Regarding short-term risk, EHC is more volatile compared to SLHGP. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check SLHGP's competition here
EHC vs AFAM Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, EHC is priced at $105.85, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas AFAM's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, EHC is less volatile compared to AFAM. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check AFAM's competition here
EHC vs NFH Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, NFH has a market cap of 0. Regarding current trading prices, EHC is priced at $105.85, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas NFH's P/E ratio is -19.75. In terms of profitability, EHC's ROE is +0.25%, compared to NFH's ROE of -0.06%. Regarding short-term risk, EHC is more volatile compared to NFH. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check NFH's competition here
EHC vs DCGOW Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, EHC is priced at $105.85, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas DCGOW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to DCGOW's ROE of -0.89%. Regarding short-term risk, EHC is less volatile compared to DCGOW. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check DCGOW's competition here
EHC vs KND Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, KND has a market cap of 0. Regarding current trading prices, EHC is priced at $105.85, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas KND's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to KND's ROE of -0.53%. Regarding short-term risk, EHC is more volatile compared to KND. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check KND's competition here
EHC vs TVTY Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, EHC is priced at $105.85, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas TVTY's P/E ratio is 19.06. In terms of profitability, EHC's ROE is +0.25%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, EHC is more volatile compared to TVTY. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check TVTY's competition here
EHC vs HNGR Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, EHC is priced at $105.85, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas HNGR's P/E ratio is 19.71. In terms of profitability, EHC's ROE is +0.25%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, EHC is more volatile compared to HNGR. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check HNGR's competition here
EHC vs SLHG Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, EHC is priced at $105.85, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas SLHG's P/E ratio is -1.48. In terms of profitability, EHC's ROE is +0.25%, compared to SLHG's ROE of N/A. Regarding short-term risk, EHC is less volatile compared to SLHG. This indicates potentially lower risk in terms of short-term price fluctuations for EHC.Check SLHG's competition here
EHC vs DVCR Comparison June 2026
EHC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 10.5B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, EHC is priced at $105.85, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 18.13, whereas DVCR's P/E ratio is 28.34. In terms of profitability, EHC's ROE is +0.25%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, EHC is more volatile compared to DVCR. This indicates potentially higher risk in terms of short-term price fluctuations for EHC.Check DVCR's competition here